Description: Citicoline (Cytidine-5-Diphosphocholine or CDP-choline) is a key intermediary in the biosynthesis of phosphatidylcholine a phospholipid, an important component of cell membranes. When administered exogenously, CDP-choline is hydrolyzed to choline and cytidine. These two important components contribute to metabolic functions such as the formation of phospholipid, nucleic acids, proteins and acetylcholine (Ach).

Indications: Neuronal damage due to ischemic, hemorrhagic strokes and after head injury or brain surgery. Rehabilitation of patients with hemeplegia following stroke.

Dosage: 250 mg BID, administered intramuscularly or intravenously or through infusion, ideally for 4-6 weeks but at least for 10 days.

How supplied: Neurocoline injection is available in pre-filled syringe system containing Citicoline 250 mg/2ml.